tempol has been researched along with aspirin in 3 studies
| Studies (tempol) | Trials (tempol) | Recent Studies (post-2010) (tempol) | Studies (aspirin) | Trials (aspirin) | Recent Studies (post-2010) (aspirin) |
|---|---|---|---|---|---|
| 19 | 0 | 15 | 48,947 | 6,817 | 13,778 |
| Protein | Taxonomy | tempol (IC50) | aspirin (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.35 | |
| Integrin beta-3 | Homo sapiens (human) | 5 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.8252 | |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 1.375 | |
| Integrin alpha-IIb | Homo sapiens (human) | 5 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.271 | |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | 2.4 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 2.15 | |
| Urotensin-2 receptor | Rattus norvegicus (Norway rat) | 0.3 | |
| 4-aminobutyrate aminotransferase, mitochondrial | Rattus norvegicus (Norway rat) | 2.4 | |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.35 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 2.4081 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, L; Bi, W; Bi, Y; Gao, X; Itagaki, Y; Li, M; Li, X; Wang, Z; Xue, P; Zhang, Y | 1 |
| Bammert, C; Bi, L; Bi, W; Bi, Y; Gao, X; Hou, S; Jockusch, S; Legalley, TD; Li, P; Michael Gibson, K; Zhang, Y | 1 |
| Barnett, NL; Bottle, SE; Fairfull-Smith, KE; Jensen, RT; Moody, TW; Rayner, CL; Ridnour, LA; Thomas, K; Tong, J; Wink, DA | 1 |
3 other study(ies) available for tempol and aspirin
| Article | Year |
|---|---|
Novel TEMPO-PEG-RGDs conjugates remediate tissue damage induced by acute limb ischemia/reperfusion.
Topics: Animals; Cyclic N-Oxides; Free Radical Scavengers; Hindlimb; Histocytochemistry; Malondialdehyde; Muscle, Skeletal; Oligopeptides; Oxidative Stress; Platelet Aggregation; Polyethylene Glycols; Rats; Reperfusion Injury; Superoxide Dismutase | 2012 |
Indole-TEMPO conjugates alleviate ischemia-reperfusion injury via attenuation of oxidative stress and preservation of mitochondrial function.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Cyclic N-Oxides; Cytochromes c; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Intestine, Small; Lipid Peroxidation; Male; Mice, Inbred ICR; Mitochondria; Molecular Dynamics Simulation; Neutrophil Infiltration; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2017 |
Design, synthesis and biological evaluation of hybrid nitroxide-based non-steroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antioxidants; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Nitrogen Oxides; Oxidative Stress; Reactive Oxygen Species; Structure-Activity Relationship | 2018 |